FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2557185850> ?p ?o ?g. }

• W2557185850 endingPage "340" @default.
• W2557185850 startingPage "329" @default.
• W2557185850 abstract "Essentials•Anti‐factor (F) VIII antibody formation is a major complication in the treatment of hemophilia A.•We investigated uptake of FVIII and FVIII immune complex by bone marrow derived dendritic cells.•Immune complex formation increased uptake of FVIII 3‐4 fold in a Fcγ receptor dependent manner.•FVIII immune complex binding to Fcγ receptors may modulate immune tolerance induction.SummaryBackgroundA major complication in the treatment of hemophilia A is the development of inhibitory antibodies targeting coagulation factor VIII (FVIII). Eradication of these inhibitors can be established by immune tolerance induction (ITI), which consists of daily administration of high dosages of FVIII. FVIII immune complexes (FVIII‐IC) could be formed following FVIII infusion in patients with pre‐existing anti‐FVIII antibodies.ObjectivesHere we studied endocytosis of FVIII‐IC by bone marrow‐derived dendritic cells (BMDCs).MethodsBMDCs were pulsed with FVIII/FVIII‐IC and uptake was assessed by flow cytometry and confocal imaging.ResultsBMDCs were able to efficiently internalize FVIII‐IC in a dose‐dependent manner, 3–4‐fold more efficiently when compared with equimolar concentrations of non‐complexed FVIII. Uptake of FVIII‐IC, but not FVIII alone, could be inhibited with anti‐Fcγ receptor (FcγR) antibody 2.4G2, indicating functional involvement of FcγR. No internalization of FVIII‐IC was observed in BMDCs lacking FcγRI, FcγRIIb, FcγRIII and FcγRIV. Genetic ablation of FcγRIIb, FcγRIII or FcγRIV individually did not affect the ability of anti‐FVIII IgG to promote the uptake of FVIII. BMDCs lacking FcγRI showed lower FVIII‐IC uptake levels when compared with other single FcγR null BMDCs. Expression of the inhibitory FcγRIIb alone was sufficient to internalize FVIII‐IC more efficiently than FVIII.ConclusionsFcγR are critical in the internalization of FVIII‐IC by BMDCs and multiple FcγR can contribute independently to this process. Our findings provide a basis for future studies to address whether the outcome of ITI is dependent on the interplay between FVIII‐IC and inhibitory and activating FcγR. Essentials•Anti‐factor (F) VIII antibody formation is a major complication in the treatment of hemophilia A.•We investigated uptake of FVIII and FVIII immune complex by bone marrow derived dendritic cells.•Immune complex formation increased uptake of FVIII 3‐4 fold in a Fcγ receptor dependent manner.•FVIII immune complex binding to Fcγ receptors may modulate immune tolerance induction. •Anti‐factor (F) VIII antibody formation is a major complication in the treatment of hemophilia A.•We investigated uptake of FVIII and FVIII immune complex by bone marrow derived dendritic cells.•Immune complex formation increased uptake of FVIII 3‐4 fold in a Fcγ receptor dependent manner.•FVIII immune complex binding to Fcγ receptors may modulate immune tolerance induction. Background A major complication in the treatment of hemophilia A is the development of inhibitory antibodies targeting coagulation factor VIII (FVIII). Eradication of these inhibitors can be established by immune tolerance induction (ITI), which consists of daily administration of high dosages of FVIII. FVIII immune complexes (FVIII‐IC) could be formed following FVIII infusion in patients with pre‐existing anti‐FVIII antibodies. Objectives Here we studied endocytosis of FVIII‐IC by bone marrow‐derived dendritic cells (BMDCs). Methods BMDCs were pulsed with FVIII/FVIII‐IC and uptake was assessed by flow cytometry and confocal imaging. Results BMDCs were able to efficiently internalize FVIII‐IC in a dose‐dependent manner, 3–4‐fold more efficiently when compared with equimolar concentrations of non‐complexed FVIII. Uptake of FVIII‐IC, but not FVIII alone, could be inhibited with anti‐Fcγ receptor (FcγR) antibody 2.4G2, indicating functional involvement of FcγR. No internalization of FVIII‐IC was observed in BMDCs lacking FcγRI, FcγRIIb, FcγRIII and FcγRIV. Genetic ablation of FcγRIIb, FcγRIII or FcγRIV individually did not affect the ability of anti‐FVIII IgG to promote the uptake of FVIII. BMDCs lacking FcγRI showed lower FVIII‐IC uptake levels when compared with other single FcγR null BMDCs. Expression of the inhibitory FcγRIIb alone was sufficient to internalize FVIII‐IC more efficiently than FVIII. Conclusions FcγR are critical in the internalization of FVIII‐IC by BMDCs and multiple FcγR can contribute independently to this process. Our findings provide a basis for future studies to address whether the outcome of ITI is dependent on the interplay between FVIII‐IC and inhibitory and activating FcγR." @default.
• W2557185850 created "2016-11-30" @default.
• W2557185850 creator A5017642120 @default.
• W2557185850 creator A5021665742 @default.
• W2557185850 creator A5034366877 @default.
• W2557185850 creator A5046414309 @default.
• W2557185850 creator A5050087953 @default.
• W2557185850 creator A5063511635 @default.
• W2557185850 creator A5066655141 @default.
• W2557185850 creator A5072522782 @default.
• W2557185850 creator A5075632762 @default.
• W2557185850 creator A5079898834 @default.
• W2557185850 creator A5086501578 @default.
• W2557185850 creator A5087783176 @default.
• W2557185850 date "2017-02-01" @default.
• W2557185850 modified "2023-10-16" @default.
• W2557185850 title "Enhanced uptake of blood coagulation factor VIII containing immune complexes by antigen presenting cells" @default.
• W2557185850 cites W1495475831 @default.
• W2557185850 cites W1500553660 @default.
• W2557185850 cites W1572321656 @default.
• W2557185850 cites W1576906505 @default.
• W2557185850 cites W1599481463 @default.
• W2557185850 cites W1599562890 @default.
• W2557185850 cites W1879113090 @default.
• W2557185850 cites W1884390340 @default.
• W2557185850 cites W1910850885 @default.
• W2557185850 cites W1915981316 @default.
• W2557185850 cites W1965808844 @default.
• W2557185850 cites W1977631644 @default.
• W2557185850 cites W1978812129 @default.
• W2557185850 cites W1980979476 @default.
• W2557185850 cites W1998614164 @default.
• W2557185850 cites W2002105236 @default.
• W2557185850 cites W2002411614 @default.
• W2557185850 cites W2002741069 @default.
• W2557185850 cites W2008996942 @default.
• W2557185850 cites W2011984976 @default.
• W2557185850 cites W2026077448 @default.
• W2557185850 cites W20271833 @default.
• W2557185850 cites W2030898001 @default.
• W2557185850 cites W2035418751 @default.
• W2557185850 cites W2047754442 @default.
• W2557185850 cites W2057408861 @default.
• W2557185850 cites W2057950690 @default.
• W2557185850 cites W2058003709 @default.
• W2557185850 cites W2061524730 @default.
• W2557185850 cites W2067954786 @default.
• W2557185850 cites W2074111056 @default.
• W2557185850 cites W2084080793 @default.
• W2557185850 cites W2091721067 @default.
• W2557185850 cites W2112592916 @default.
• W2557185850 cites W2112961788 @default.
• W2557185850 cites W2117085497 @default.
• W2557185850 cites W2122877291 @default.
• W2557185850 cites W2134792382 @default.
• W2557185850 cites W2135287644 @default.
• W2557185850 cites W2141853833 @default.
• W2557185850 cites W2143239528 @default.
• W2557185850 cites W2143929903 @default.
• W2557185850 cites W2161704057 @default.
• W2557185850 cites W2165641132 @default.
• W2557185850 cites W2165835604 @default.
• W2557185850 cites W2176247280 @default.
• W2557185850 cites W2196289212 @default.
• W2557185850 cites W2328011698 @default.
• W2557185850 cites W2405254939 @default.
• W2557185850 cites W2410247943 @default.
• W2557185850 cites W2463594392 @default.
• W2557185850 cites W290369176 @default.
• W2557185850 cites W4249487565 @default.
• W2557185850 doi "https://doi.org/10.1111/jth.13570" @default.
• W2557185850 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27868337" @default.
• W2557185850 hasPublicationYear "2017" @default.
• W2557185850 type Work @default.
• W2557185850 sameAs 2557185850 @default.
• W2557185850 citedByCount "12" @default.
• W2557185850 countsByYear W25571858502017 @default.
• W2557185850 countsByYear W25571858502018 @default.
• W2557185850 countsByYear W25571858502020 @default.
• W2557185850 countsByYear W25571858502021 @default.
• W2557185850 countsByYear W25571858502022 @default.
• W2557185850 countsByYear W25571858502023 @default.
• W2557185850 crossrefType "journal-article" @default.
• W2557185850 hasAuthorship W2557185850A5017642120 @default.
• W2557185850 hasAuthorship W2557185850A5021665742 @default.
• W2557185850 hasAuthorship W2557185850A5034366877 @default.
• W2557185850 hasAuthorship W2557185850A5046414309 @default.
• W2557185850 hasAuthorship W2557185850A5050087953 @default.
• W2557185850 hasAuthorship W2557185850A5063511635 @default.
• W2557185850 hasAuthorship W2557185850A5066655141 @default.
• W2557185850 hasAuthorship W2557185850A5072522782 @default.
• W2557185850 hasAuthorship W2557185850A5075632762 @default.
• W2557185850 hasAuthorship W2557185850A5079898834 @default.
• W2557185850 hasAuthorship W2557185850A5086501578 @default.
• W2557185850 hasAuthorship W2557185850A5087783176 @default.
• W2557185850 hasConcept C126322002 @default.
• W2557185850 hasConcept C139770010 @default.
• W2557185850 hasConcept C147483822 @default.

• next